Clinical Trials on Clostridia Difficile Colitis in Belgium

Total 187 results

Astellas Pharma Europe Ltd.
Merck Sharp & Dohme LLC

Completed

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population (EXTEND)

Clostridium Difficile

Greece, Spain, Russian Federation, Denmark, Austria, Belgium, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, United Kingdom
Astellas Pharma Europe B.V.
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD) (SUNSHINE)

Clostridium Difficile-associated Diarrhea (CDAD)

United States, Belgium, Italy, Canada, France, Germany, Hungary, Poland, Romania, Spain
Summit Therapeutics

Completed

To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (Ri-CoDIFy 2)

Clostridioides Difficile Infection

United States, Spain, France, Canada, Belgium, Israel, Chile, Belarus, Latvia, Germany, Romania, Lithuania, Mexico, Czechia, Estonia, Georgia, Peru
Actelion

Terminated

Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)

Clostridium Difficile Infection

United States, Belgium, Canada, Czechia, Hungary, Italy, Poland, Romania, Spain
Pfizer

Completed

Clostridium Difficile Vaccine Efficacy Trial (Clover)

Clostridium Difficile Infection

United States, Spain, Belgium, Taiwan, Japan, Portugal, Colombia, Korea, Republic of, Poland, Australia, Germany, Canada, Argentina, Bulgaria, Chile, Czechia, Finland, France, Hungary, Peru, Slovakia, Sweden, United Kingdom
Actelion

Completed

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea

Clostridium Difficile Infection

United States, Belgium, Israel, Argentina, Brazil, Canada, Chile, Croatia, Czechia, Greece, Hungary, Korea, Republic of, Romania, Slovakia
Shire

Completed

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

Clostridium Difficile Infection

United States, Belgium, Canada, Germany, Switzerland, Spain
University of Liege

Unknown

Effect of LPEC Compared With a Sham Procedure in the General Anesthesia

Intubation;Difficult

Belgium
Imelda GI Clinical Research Center

Completed

pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis (APOLLO)

Ulcerative Colitis

Belgium
KU Leuven

Completed

Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis

Ulcerative Colitis

Belgium
Abivax S.A.
Orion Corporation, Orion Pharma

Active, not recruiting

Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Shire

Completed

Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium
Abivax S.A.

Completed

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
University of Liege; University Hospital, Ghent; Imelda Hospital, Bonheiden; AZ... and other collaborators

Completed

Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis (CEDAR UC)

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
Imelda GI Clinical Research Center; Sapporo Medical University

Unknown

PRognOstiC valuE of rEd Density in Ulcerative Colitis (PROCEED-UC)

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Unknown

Golimumab Dried Blood Spot Analysis (GOUDA)

Ulcerative Colitis

Belgium
Universitaire Ziekenhuizen KU Leuven
Fund for Scientific Research, Flanders, Belgium

Unknown

Restoration of the Microbiome Through Superdonor Selection (RESTORE-UC)

Ulcerative Colitis

Belgium
KU Leuven

Recruiting

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

Healthy Controls | IBS | Ulcerative Colitis, Active | Ulcerative Colitis, Remission (3a: With IBS Symptoms, 3b: Without IBS Symptoms) | Crohn's Disease, Active | Crohn's Disease, Remission (6a: With IBS Symptoms, 6b: Without IBS Symptoms)

Belgium
Universitaire Ziekenhuizen KU Leuven
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

Unknown

Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny (HELP-AID)

Crohn Disease | Colitis, Ulcerative

Belgium
Universitaire Ziekenhuizen KU Leuven
Vlaams Instituut Biotechnologie (VIB)

Recruiting

Drug Repurposing - Statins as Microbiota Modulating Agents in Ulcerative Colitis (ReMiDy)

Ulcerative Colitis

Belgium
Shire

Completed

Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476

Colitis, Ulcerative

Belgium
Universitaire Ziekenhuizen KU Leuven
McGill University; Maastricht University Medical Center; Copenhagen University... and other collaborators

Unknown

Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis

Ulcerative Colitis

Belgium, Canada, Denmark, Netherlands
Hoffmann-La Roche

Terminated

A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease (FENNEL)

Crohn's Disease | Ulcerative Colitis

Poland, United Kingdom, Belgium, Spain
Abivax S.A.

Active, not recruiting

Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

Belgium, Poland, Czechia, Hungary
Boehringer Ingelheim

Completed

This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients

Colitis, Ulcerative

Belgium, Germany, United Kingdom
Belgian Inflammatory Bowel Disease Research and...
Ferring Pharmaceuticals

Completed

ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA (CARUC-ASA)

Ulcerative Colitis

Belgium
Shire

Completed

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs (TOSCA)

Crohn's Disease | Ulcerative Colitis | Ileitis | Granulomatous Colitis | Ileo-colonic and Colonic Crohn's Disease | Regional Enteritis

France, Belgium, Austria, Germany, Netherlands
ActoGeniX N.V.

Completed

A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis

Moderately Active Ulcerative Colitis

Canada, Netherlands, Sweden, Belgium
University Hospital, Ghent

Withdrawn

The Effect of Osteopatic Cranial Techniques on the Audiometric and Tympanometric Values in Children Suffering From Otitis Media With Effusion.

Otitis Media With Effusion

Belgium
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (In-TARGET)

ULCERATIVE COLITIS

France, Belgium
Takeda

Active, not recruiting

A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)

Inflammatory Bowel Diseases | Colitis, Ulcerative | Crohns Disease

Belgium
University Hospital, Antwerp

Completed

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

Probiotics | Otitis Media With Effusion | Adenoid Vegetations

Belgium
Galapagos NV

Completed

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

Ulcerative Colitis

Belgium, Czech Republic, Slovakia, Latvia
GlaxoSmithKline

Withdrawn

A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

Colitis, Ulcerative

Netherlands, Belgium, United Kingdom
Novartis Pharmaceuticals

Terminated

Efficacy & Safety in Moderately Active Refractory Ulcerative Colitis Patients

Ulcerative Colitis

Belgium, Hungary, Switzerland, Germany, Sweden, United Kingdom
Palau Pharma S.A.

Completed

A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

Belgium, Hungary, Slovakia, Spain
GlaxoSmithKline

Completed

Safety and Immunogenicity Study of GSK's Clostridium Difficile Vaccine 2904545A When Administered in Healthy Adults Aged 18-45 Years and 50-70 Years

Clostridium Infections

Belgium
University Hospital, Antwerp
Universiteit Antwerpen

Completed

The URT and Middle Ear Microbiota in Health and During Chronic OME

Healthy | Otitis Media With Effusion

Belgium
University Medical Center Groningen
Bühlmann Laboratories AG; European Crohn´s and Colitis Organisation

Enrolling by invitation

De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease (FREE)

Inflammatory Bowel Diseases | Crohn Disease | Colitis, Ulcerative

Belgium, Netherlands, Spain
Janssen Research & Development, LLC

Suspended

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Crohn Disease | Ulcerative Colitis

Germany, United States, United Kingdom, Belgium
Avaxia Biologics, Incorporated

Completed

Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis

Ulcerative Colitis

United States, Hungary, Belgium, Canada
Centre Hospitalier Universitaire de Besancon

Completed

Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis (METEOR)

Ulcerative Colitis

France, Italy, Austria, Belgium, Israel, Netherlands
Geert D'Haens
Takeda

Completed

An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis (LOVE-UC)

Colitis, Ulcerative

Netherlands, Belgium, Hungary
Galapagos NV

Completed

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis (ORIGIN)

Ulcerative Colitis

Belgium, Czech Republic, Germany, Hungary, Poland, Russian Federation
Gilead Sciences

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Netherlands, Canada, Hungary, Moldova, Republic of, Romania
Sanofi

Completed

Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NICE)

Ulcerative Colitis | Inflammatory Bowel Disease

Canada, Brazil, Russian Federation, Italy, Spain, Sweden, Estonia, Singapore, Belgium, Czech Republic, Argentina, Hungary, Chile, South Africa
Groupe d'Etude Therapeutique des Affections Inflammatoires...

Completed

Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis (CYSIF)

Ulcerative Colitis | Steroid Refractory

France, Spain, Belgium, Finland, Italy
Landos Biopharma Inc.

Recruiting

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Ulcerative Colitis

United States, Belgium, Italy, Poland
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Pfizer

Terminated

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Ulcerative Colitis

United States, Australia, Italy, Korea, Republic of, Belgium, Israel, Turkey, Saudi Arabia, Germany, Serbia

Clinical Trials on Clostridia Difficile Colitis in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations